The DLG1-AS1/miR-497/YAP1 axis regulates papillary thyroid cancer progression

被引：2
|
作者：
Huang, Yong [1 ]
Zhang, KeWei [2 ]
Li, Yinghua [1 ]
Dai, Yuyin [1 ]
Zhao, Hongguang [1 ]
机构：
[1] First Hosp Jilin Univ, Dept Nucl Med, Changchun 130021, Peoples R China
[2] First Hosp Jilin Univ, Dept Thorac Surg, Changchun 130021, Peoples R China
来源：
AGING-US | 2020年 / 12卷 / 22期
关键词：
papillary thyroid cancer; DLG1-AS1; miR-497; YAP1; lncRNA; LONG NONCODING RNAS; PROLIFERATION; CARCINOMA; MIGRATION; INVASION; GROWTH;
D O I：
暂无
中图分类号：
Q2 [细胞生物学];
学科分类号：
071009 ; 090102 ;
摘要：
The long non-coding RNA (lncRNA), DLG1-AS1, is upregulated in papillary thyroid cancer (PTC) tissues and cell lines. Here, we found that increased expression of DLG1-AS1 caused lymph node metastasis and advanced tumor-node-metastasis (TNM) stage. DLG1-AS1 knockdown inhibited proliferation, invasion, and migration of PTC cells, and impaired tumorigenesis in vivo in mouse xenografts. DLG1-AS1 functions as a competing endogenous RNA (ceRNA) for miR-497. Further investigation revealed that DLG1-AS1 regulated yes-associated protein 1 (YAP1; a known target of miR-497) by competitively binding to miR-497. Moreover, inhibition of miR497 abrogated the inhibitory effects of DLG1-AS1 depletion on PTC cells. These findings demonstrate that the DLG1-AS1-miR-497-YAP1 axis promotes the growth and metastasis of PTC by forming a ceRNA network.
引用
收藏
页码：23326 / 23336
页数：11
相关论文
共 50 条
  • [21] miR-205 targets YAP1 and inhibits proliferation and invasion in thyroid cancer cells
    Li, Dewei
    Wang, Qiang
    Li, Ning
    Zhang, Shuilong
    MOLECULAR MEDICINE REPORTS, 2018, 18 (02) : 1674 - 1681
  • [22] RETRACTED: miR-497 inhibited proliferation, migration and invasion of thyroid papillary carcinoma cells by negatively regulating YAP1 expression (Retracted article. See vol. 16, pg. 47, 2023)
    Cheng, Hui
    Dong, Hui
    Feng, Jianlin
    Tian, Hongyan
    Zhang, Haixia
    Xu, Lina
    ONCOTARGETS AND THERAPY, 2018, 11 : 4711 - 4721
  • [23] Targeting YAP1/LINC00152/FSCN1 Signaling Axis Prevents the Progression of Colorectal Cancer
    Ou, Chunlin
    Sun, Zhenqiang
    He, Xiaoyun
    Li, Xiaoling
    Fan, Songqing
    Zheng, Xiang
    Peng, Qiu
    Li, Guiyuan
    Li, Xiayu
    Ma, Jian
    ADVANCED SCIENCE, 2020, 7 (03)
  • [24] Interaction of YAP1 and mTOR promotes bladder cancer progression
    Xu, Mingxi
    Gu, Meng
    Zhou, Juan
    Da, Jun
    Wang, Zhong
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2020, 56 (01) : 232 - 242
  • [25] LncRNA PVT1 regulates biological function of osteoarthritis cells by regulating miR-497/AKT3 axis
    Xu, Jinming
    Fang, Xiang
    Qin, Ling
    Wu, Qiang
    Zhan, Xinli
    MEDICINE, 2022, 101 (45) : E31725
  • [26] LncRNA DLG1-AS1 Promotes Cancer Cell Proliferation in Triple Negative Breast Cancer by Downregulating miR-203
    Li, Shuyan
    JOURNAL OF BREAST CANCER, 2020, 23 (04) : 343 - 354
  • [27] LncRNA SNHG1 Promotes the Progression of Pancreatic Cancer by Regulating FGFR1 Expression via Competitively Binding to miR-497
    Chen, Shihong
    Guo, Wenyi
    Meng, Mingyang
    Wu, Dong
    Zhou, Tao
    Wang, Lei
    Xu, Jianwei
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [28] NEK1-mediated phosphorylation of YAP1 is key to prostate cancer progression
    Olatunde, Damilola M.
    Ghosh, Ishita
    De Benedetti, Arrigo
    CANCER RESEARCH, 2024, 84 (06)
  • [29] NEK1-Mediated Phosphorylation of YAP1 Is Key to Prostate Cancer Progression
    Ghosh, Ishita
    Khalil, Md Imtiaz
    Mirza, Rusella
    King, Judy
    Olatunde, Damilola
    De Benedetti, Arrigo
    BIOMEDICINES, 2023, 11 (03)
  • [30] MiR-195-5p Inhibits Malignant Progression of Cervical Cancer by Targeting YAP1
    Liu, Xiaomin
    Zhou, Yi
    Ning, Yu-e
    Gu, Hui
    Tong, Yuxin
    Wang, Ning
    ONCOTARGETS AND THERAPY, 2020, 13 : 931 - 944
12345